Author

Bianca Garlisi

University of GuelphORCID 0009-0003-0671-2148Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

Aditya N. BrahmbhattiD· 2 shared Brooke A. Morris· 2 shared Caroline Aitken· 2 shared Christopher G. R. PerryiD· 2 shared Jeremy A. SimpsoniD· 2 shared Jim PetrikiD· 2 shared Leslie M. OgilvieiD· 2 shared Luca J. DelfinisiD· 2 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPhysiology

Aditya N. BrahmbhattORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

PhysiologyThe Journal of PhysiologyPeer-reviewedNov 2, 2025

The mitochondrial-targeted antioxidant SkQ1 prevents mitochondrial-linked apoptosis but not necroptosis or skeletal muscle atrophy in ovarian cancer

Shahrzad Khajehzadehshoushtar, Luca J. Delfinis, Fasih Ahmad Rahman…·Christopher G. R. Perry

This paper investigates the role of mitochondrial ROS in skeletal muscle atrophy during ovarian cancer and finds that SkQ1 reduces mitochondrial-linked apoptosis but not necroptosis or atrophy.

3 citations

mouseproteomics

𝕏 PostBluesky

PhysiologyMolecular MetabolismPeer-reviewedJul 17, 2025

Mitochondrial-targeted plastoquinone therapy ameliorates early onset muscle weakness that precedes ovarian cancer cachexia in mice

Luca J. Delfinis, Shahrzad Khajehzadehshoushtar, Luke D. Flewwelling…·Christopher G. R. Perry

This study shows mitochondrial-targeted plastoquinone SkQ1 reduces early muscle weakness in ovarian cancer mice by improving calcium handling and mitochondrial function, without preventing atrophy.

5 citations

mouseexperimental assay

𝕏 PostBluesky